146 related articles for article (PubMed ID: 17579620)
1. Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model.
Modok S; Scott R; Alderden RA; Hall MD; Mellor HR; Bohic S; Roose T; Hambley TW; Callaghan R
Br J Cancer; 2007 Jul; 97(2):194-200. PubMed ID: 17579620
[TBL] [Abstract][Full Text] [Related]
2. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
3. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
4. Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light.
Kratochwil NA; Bednarski PJ; Mrozek H; Vogler A; Nagle JK
Anticancer Drug Des; 1996 Mar; 11(2):155-71. PubMed ID: 8630187
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines.
Hall MD; Amjadi S; Zhang M; Beale PJ; Hambley TW
J Inorg Biochem; 2004 Oct; 98(10):1614-24. PubMed ID: 15458824
[TBL] [Abstract][Full Text] [Related]
6. Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake.
Oldfield SP; Hall MD; Platts JA
J Med Chem; 2007 Oct; 50(21):5227-37. PubMed ID: 17900102
[TBL] [Abstract][Full Text] [Related]
7. Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: experimental and mathematical modelling.
Modok S; Hyde P; Mellor HR; Roose T; Callaghan R
Eur J Cancer; 2006 Sep; 42(14):2404-13. PubMed ID: 16901688
[TBL] [Abstract][Full Text] [Related]
8. Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells.
New EJ; Duan R; Zhang JZ; Hambley TW
Dalton Trans; 2009 Apr; (16):3092-101. PubMed ID: 19352538
[TBL] [Abstract][Full Text] [Related]
9. Extravascular transport of drugs in tumor tissue: effect of lipophilicity on diffusion of tirapazamine analogues in multicellular layer cultures.
Pruijn FB; Sturman JR; Liyanage HD; Hicks KO; Hay MP; Wilson WR
J Med Chem; 2005 Feb; 48(4):1079-87. PubMed ID: 15715475
[TBL] [Abstract][Full Text] [Related]
10. [Pt(HPxSC)Cl(3)], a novel platinum(IV) compound with anticancer properties.
Marković M; Knezević N; Momcilović M; Grgurić-Sipka S; Harhaji L; Trajković V; Mostarica Stojković M; Sabo T; Miljković D
Eur J Pharmacol; 2005 Jul; 517(1-2):28-34. PubMed ID: 15970285
[TBL] [Abstract][Full Text] [Related]
11. Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.
Knipp M; Karotki AV; Chesnov S; Natile G; Sadler PJ; Brabec V; Vasák M
J Med Chem; 2007 Aug; 50(17):4075-86. PubMed ID: 17665893
[TBL] [Abstract][Full Text] [Related]
12. Extravascular transport of the DNA intercalator and topoisomerase poison N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA): diffusion and metabolism in multicellular layers of tumor cells.
Hicks KO; Pruijn FB; Baguley BC; Wilson WR
J Pharmacol Exp Ther; 2001 Jun; 297(3):1088-98. PubMed ID: 11356933
[TBL] [Abstract][Full Text] [Related]
13. Chemical, structural and biological studies of cis-[Pt(3-Acpy)(2)Cl(2)].
Tian T; Mutikainen I; van Wezel GP; Aliaga-Alcalde N; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1221-7. PubMed ID: 19635634
[TBL] [Abstract][Full Text] [Related]
14. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
15. Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dog.
Pendyala L; Cowens JW; Creaven PJ
Cancer Treat Rep; 1982 Mar; 66(3):509-16. PubMed ID: 7060038
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
17. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug.
Alderden RA; Mellor HR; Modok S; Hambley TW; Callaghan R
Biochem Pharmacol; 2006 Apr; 71(8):1136-45. PubMed ID: 16458859
[TBL] [Abstract][Full Text] [Related]
19. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC5H4N)2(PTA)2], and trans-[Pt(SC5H4N)2(DAPTA)2].
Miranda S; Vergara E; Mohr F; de Vos D; Cerrada E; Mendía A; Laguna M
Inorg Chem; 2008 Jul; 47(13):5641-8. PubMed ID: 18447334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
